Caribou Biosciences, Inc. CRBU
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-23
Caribou Biosciences, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,947,820 | $11.4M | 7.3% |
| RENAISSANCE TECHNOLOGIES LLC | 2,773,545 | $4.9M | 2.92% |
| TWO SIGMA INVESTMENTS, LP | 1,046,279 | $1.8M | 1.1% |
| CITADEL ADVISORS LLC | 197,815 | $348,154 | 0.21% |
| MILLENNIUM MANAGEMENT LLC | 51,171 | $90,061 | 0.05% |
| Point72 Asset Management, L.P. | 15,769 | $27,753 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.